Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

5.905 -0.285 (-4.60%)
Streaming Delayed Price Updated: 3:19 PM EDT, May 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
62 63 Next >
Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today?
U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%. 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
The company can now join Pfizer and Moderna in launching an updated booster in the U.S. 
Via Investor's Business Daily
Exposures COVID-19 Product Safety
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S. 
Via Benzinga
Exposures COVID-19 Product Safety
Why Pfizer and BioNTech Stocks Zoomed Higher Today
The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle. 
Via The Motley Fool
Exposures COVID-19
NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month
With the market suffering losses due to broader headwinds, hedge funds have targeted the most shorted stocks for cynical profits. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Up 20% in 1 Month, Is This Stock a Buy?
As Covid cases rise, Novavax is getting more attention again. But will the momentum last? 
Via The Motley Fool
Exposures COVID-19
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks. 
Via InvestorPlace
Does This Message From Moderna Mean Bad News for Novavax?
So far, Novavax has lagged behind Moderna when it comes to bringing a vaccine to market. 
Via The Motley Fool
You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10
These stocks look cheap right now -- if the companies can meet their goals. 
Via The Motley Fool
Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now?
When it comes to Big Pharma, Japan’s Takeda Pharmaceutical Co Ltd (NYSE: TAK) is a conservative play that could prove to be a big winner given its cheap valuation and suite of new drugs that portend to... 
Via Benzinga
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get... 
Via Benzinga
Exposures COVID-19 Product Safety
Why COVID Vaccine Demand Might Not Be That Strong
COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago. 
Via The Motley Fool
Exposures COVID-19
Novavax Is a Step Behind, Again. Should You Be Worried?
The FDA still is reviewing Novavax's updated vaccine candidate. 
Via The Motley Fool
Exposures Product Safety
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories
Benzinga 
Via Benzinga
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Tending Today
U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
The U.S. 
Via Benzinga
Exposures COVID-19 Product Safety
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
Novavax says it's working with the FDA to answer final requests as part of the agency's review. 
Via Investor's Business Daily
Exposures COVID-19 Product Safety
7 Biotech Stocks to Sell in September Before They Crash & Burn
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues. 
Via InvestorPlace
Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry
On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the... 
Via Benzinga
Exposures COVID-19
Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant
Pirola has about 30 mutations compared with previous omicron versions of the virus. 
Via Investor's Business Daily
Exposures COVID-19
This Down-on-Its-Luck Biotech Could Surge 150%, Wall Street Says. Should You Buy the Stock?
Today, Novavax is getting ready to compete in the fall vaccine market -- one that's in transition. 
Via The Motley Fool
Novavax, Zscaler, Digital Brands Group, Asana, Tesla: Why These 5 Stocks Are Drawing Investor Attention Today
Via Benzinga
Why Novavax Stock Rocketed 10% Higher Today
The COVID vaccine maker benefits on a day when worries about a surge intensify with a new case at the White House. 
Via The Motley Fool
Exposures COVID-19
Why Novavax Stock Traded Higher Today
Novavax, Inc. (NASDAQ: NVAX) shares trader higher Tuesday amid rising COVID cases in the US, which has lifted vaccine stocks in recent weeks. 
Via Benzinga
Exposures COVID-19
Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?
Investors have worried about vaccine revenue in a post-pandemic world. 
Via The Motley Fool
Exposures COVID-19
2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
The second quarter of the 2023 earnings season has drawn to a close. There were many surprises in every sector. However, there were some standout surprises with 
Via MarketBeat
Exposures COVID-19
7 Undervalued Stocks Due for a Massive Short Squeeze
These are the undervalued short squeeze candidates and these stocks represent fundamentally strong growth companies 
Via InvestorPlace
3 Biotech Stocks Due for a Massive Short Squeeze
These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters. 
Via InvestorPlace
Should You Buy Novavax's Stock Before the FDA Approves Its New COVID Shot?
The vaccine's approval could come within weeks. 
Via The Motley Fool
Exposures COVID-19 Product Safety
3 of Wall Street’s Most Shorted Stocks Due for a Massive Short Squeeze
These are the most shorted stocks trading in the U.S. stock market, and any good news could put their short sellers into a serious bind. 
Via InvestorPlace
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
62 63 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.